YIH
CLBT icon

Y-Intercept (HK)’s Cellebrite CLBT Stock Holding History

Y-Intercept (HK)’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$688K Buy
+47,148
New +$623K 0.01% 1204
2025
Q3 		– Sell
-41,034
Closed -$657K – 1619
2025
Q2 		$657K Buy
+41,034
New +$732K 0.02% 1103
2025
Q1 		– Sell
-26,811
Closed -$591K – 1249
2024
Q4 		$591K Buy
26,811
+7,301
+37% +$141K 0.04% 652
2024
Q3 		$329K Buy
19,510
+5,113
+36% +$75.9K 0.02% 974
2024
Q2 		$172K Buy
+14,397
New +$161K 0.01% 1200

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Y-Intercept (HK)'s CLBT Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Cellebrite (CLBT) in Q2 2026: 47,148 shares worth $688K. The stake represents 0.01% of the portfolio and ranks #1204 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in CLBT as recently as Q2 2025.

Y-Intercept (HK) first reported a position in CLBT in Q2 2024 and has held it in 5 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Y-Intercept (HK) held 47,148 shares of Cellebrite worth $688K as of Q2 2026.
  • Cellebrite was a new Y-Intercept (HK) position in Q2 2026.
  • Cellebrite made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1204 holding.
  • Y-Intercept (HK) first reported a position in Cellebrite in Q2 2024 and has held it in 5 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.